
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 1ABBV market cap is 346.29B. The company's latest EPS is USD 2.4233 and P/E is 88.50.
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 45.8B | 56.2B | 58.05B | 54.5B | 56.34B |
Operating Income | 11.36B | 17.92B | 18.12B | 12.76B | 9.14B |
Net Income | 4.62B | 11.54B | 11.84B | 4.86B | 4.28B |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 150.57B | 146.53B | 138.81B | 134.71B | 135.16B |
Total Liabilities | 137.47B | 131.09B | 121.52B | 124.31B | 131.8B |
Total Equity | 13.1B | 15.44B | 17.29B | 10.4B | 3.36B |
Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 17.59B | 22.78B | 24.94B | 22.84B | 18.81B |
Investing | -37.56B | -2.34B | -623M | -2.01B | -20.82B |
Financing | -11.5B | -19.04B | -24.8B | -17.22B | -5.21B |
Market Cap | 346.29B |
Price to Earnings Ratio | 88.50 |
Price to Sales Ratio | 6.72 |
Price to Cash Ratio | 68.54 |
Price to Book Ratio | 112.55 |
Dividend Yield | 3.65% |
Shares Outstanding | 1.77B |
Average Volume (1 week) | 171 |
Average Volume (1 Month) | 75 |
52 Week Change | 18.24% |
52 Week High | 202.55 |
52 Week Low | 143.42 |
Spread (Intraday) | 0.46 (0.23%) |
Company Name | Abbvie Inc |
Address |
1521 concord pike suite 201 wilmington, delaware 19803 |
Website | https://www.abbvie.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions